Form 8-K - Current report:
SEC Accession No. 0001144204-13-022615
Filing Date
2013-04-18
Accepted
2013-04-18 09:36:04
Documents
19
Period of Report
2013-04-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v341771_8k.htm 8-K 12877
2 EXHIBIT 99.1 v341771_ex99-1.htm EX-99.1 21956
3 GRAPHIC image_001.jpg GRAPHIC 20610
4 GRAPHIC image_002.jpg GRAPHIC 103518
5 GRAPHIC image_003.jpg GRAPHIC 52122
6 GRAPHIC image_004.jpg GRAPHIC 64688
7 GRAPHIC image_005.jpg GRAPHIC 68425
8 GRAPHIC image_006.jpg GRAPHIC 59841
9 GRAPHIC image_007.jpg GRAPHIC 19306
10 GRAPHIC image_008.jpg GRAPHIC 60573
11 GRAPHIC image_009.jpg GRAPHIC 77102
12 GRAPHIC image_010.jpg GRAPHIC 66573
13 GRAPHIC image_011.jpg GRAPHIC 45198
14 GRAPHIC image_012.jpg GRAPHIC 39520
15 GRAPHIC image_013.jpg GRAPHIC 17789
16 GRAPHIC image_014.jpg GRAPHIC 79151
17 GRAPHIC image_015.jpg GRAPHIC 59850
18 GRAPHIC image_016.jpg GRAPHIC 52026
19 GRAPHIC image_017.jpg GRAPHIC 74548
  Complete submission text file 0001144204-13-022615.txt   1362235
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-184487 | Film No.: 13768355
SIC: 2833 Medicinal Chemicals & Botanical Products